Bitterman Robert J 4
4 · Phio Pharmaceuticals Corp. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Bitterman Robert J
DirectorChairman, Pres. & CEO
Transactions
- Purchase
Common stock, $0.0001 par value
2023-07-01$2.84/sh+1,000$2,840→ 19,211 total - Purchase
Common stock, $0.0001 par value
2023-06-30$2.88/sh+1,000$2,880→ 18,211 total
Footnotes (1)
- [F1]Includes shares of common stock underlying unvested restricted stock units.